Nanobiotix Files 6-K Report
Ticker: NBTX · Form: 6-K · Filed: Apr 20, 2026 · CIK: 0001760854
Sentiment: neutral
Topics: foreign-issuer, sec-filing, press-release
TL;DR
Nanobiotix filed a 6-K on 4/20/26 with a press release attached.
AI Summary
Nanobiotix S.A. filed a Form 6-K on April 20, 2026, reporting information as a foreign issuer. The filing includes a press release as Exhibit 99.1. The company's mailing and business address is 60 Rue de Wattignies, Paris, France.
Why It Matters
This filing indicates Nanobiotix is providing updated information to the SEC, which could include significant business developments or financial updates relevant to investors.
Risk Assessment
Risk Level: low — A 6-K filing is a routine report for foreign issuers and does not inherently signal high risk.
Key Players & Entities
- Nanobiotix S.A. (company) — Filer
- 0001760854 (company) — CIK Number
- 2026-04-20 (date) — Filing Date
- 60 RUE DE WATTIGNIES PARIS I0 75012 (address) — Mailing and Business Address
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a report of a foreign issuer.
When was this filing accepted by the SEC?
The filing was accepted on 2026-04-20 at 06:00:20.
What is the CIK number for Nanobiotix S.A.?
The CIK number for Nanobiotix S.A. is 0001760854.
What is Nanobiotix S.A.'s business address?
Nanobiotix S.A.'s business address is 60 Rue de Wattignies, Paris I0 75012.
What document is included as Exhibit 99.1?
Exhibit 99.1 is a press release.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 20, 2026 regarding Nanobiotix S.A. (NBTX).